• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺特异性膜抗原是一种多功能蛋白吗?

Is prostate-specific membrane antigen a multifunctional protein?

作者信息

Rajasekaran Ayyappan K, Anilkumar Gopalakrishnapillai, Christiansen Jason J

机构信息

Dept. of Pathology and Laboratory Medicine, David Geffen School of Medicine, Univ. of California, Los Angeles, 10833 Le Conte Ave., Rm. 13-344, CHS, Los Angeles, CA 90095, USA.

出版信息

Am J Physiol Cell Physiol. 2005 May;288(5):C975-81. doi: 10.1152/ajpcell.00506.2004.

DOI:10.1152/ajpcell.00506.2004
PMID:15840561
Abstract

Prostate-specific membrane antigen (PSMA) is a metallopeptidase expressed predominantly in prostate cancer (PCa) cells. PSMA is considered a biomarker for PCa and is under intense investigation for use as an imaging and therapeutic target. Although the clinical utility of PSMA in the detection and treatment of PCa is evident and is being pursued, very little is known about its basic biological function in PCa cells. The purpose of this review is to highlight the possibility that PSMA might be a multifunctional protein. We suggest that PSMA may function as a receptor internalizing a putative ligand, an enzyme playing a role in nutrient uptake, and a peptidase involved in signal transduction in prostate epithelial cells. Insights into the possible functions of PSMA should improve the diagnostic and therapeutic values of this clinically important molecule.

摘要

前列腺特异性膜抗原(PSMA)是一种主要在前列腺癌细胞(PCa)中表达的金属肽酶。PSMA被认为是前列腺癌的生物标志物,目前正作为成像和治疗靶点进行深入研究。尽管PSMA在前列腺癌检测和治疗中的临床应用已很明显且正在进行中,但对其在前列腺癌细胞中的基本生物学功能却知之甚少。本综述的目的是强调PSMA可能是一种多功能蛋白的可能性。我们认为,PSMA可能作为内化假定配体的受体、在营养物质摄取中发挥作用的酶以及参与前列腺上皮细胞信号转导的肽酶。深入了解PSMA的可能功能应能提高这一临床重要分子的诊断和治疗价值。

相似文献

1
Is prostate-specific membrane antigen a multifunctional protein?前列腺特异性膜抗原是一种多功能蛋白吗?
Am J Physiol Cell Physiol. 2005 May;288(5):C975-81. doi: 10.1152/ajpcell.00506.2004.
2
Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity.前列腺特异性膜抗原与细丝蛋白A的关联调节其内化作用和N-乙酰-α-神经氨酸酶活性。
Cancer Res. 2003 May 15;63(10):2645-8.
3
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.肿瘤靶点前列腺特异性膜抗原(PSMA)及其在前列腺癌中的调控
J Cell Biochem. 2004 Feb 15;91(3):528-39. doi: 10.1002/jcb.10661.
4
Current application and future perspectives of prostate specific membrane antigen PET imaging in prostate cancer.前列腺特异性膜抗原PET成像在前列腺癌中的当前应用及未来展望
Q J Nucl Med Mol Imaging. 2019 Mar;63(1):7-18. doi: 10.23736/S1824-4785.18.03059-5. Epub 2018 Mar 8.
5
PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges.前列腺癌中前列腺特异性膜抗原的正电子发射断层显像:当前技术水平与未来挑战
Prostate Cancer Prostatic Dis. 2016 Sep;19(3):223-30. doi: 10.1038/pcan.2016.13. Epub 2016 May 3.
6
Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments.先进前列腺癌的治疗策略:当前的适应证和未来的发展。
Eur Urol Oncol. 2019 Mar;2(2):152-162. doi: 10.1016/j.euo.2019.01.001. Epub 2019 Jan 31.
7
PSMA PET and Radionuclide Therapy in Prostate Cancer.前列腺癌中的前列腺特异性膜抗原正电子发射断层扫描与放射性核素治疗
Semin Nucl Med. 2016 Nov;46(6):522-535. doi: 10.1053/j.semnuclmed.2016.07.006. Epub 2016 Sep 3.
8
Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction.前列腺特异性膜抗原通过调节整合素信号转导来调控血管生成。
Mol Cell Biol. 2006 Jul;26(14):5310-24. doi: 10.1128/MCB.00084-06.
9
Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells.鉴定与前列腺癌细胞中 PSMA 示踪剂摄取相关的谷氨酸-脲基-赖氨酸的替代蛋白靶标。
Proc Natl Acad Sci U S A. 2022 Jan 25;119(4). doi: 10.1073/pnas.2025710119.
10
PSMA PET/CT for staging and treatment of prostate cancer.前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描用于前列腺癌的分期和治疗。
Clin Adv Hematol Oncol. 2019 Jul;17(7):370-373.

引用本文的文献

1
Prostate-Specific Membrane Antigen Expression in Colorectal Cancer and Its Potential Implication in Disease Monitoring in Rectal Cancer.前列腺特异性膜抗原在结直肠癌中的表达及其在直肠癌疾病监测中的潜在意义。
J Gastrointest Cancer. 2025 Jul 19;56(1):159. doi: 10.1007/s12029-025-01277-x.
2
CXCR2 expression is associated with prostate-specific membrane antigen expression in hepatocellular carcinoma: reappraisal of tumor microenvironment and angiogenesis.CXCR2表达与肝细胞癌中前列腺特异性膜抗原表达相关:肿瘤微环境与血管生成的重新评估
Clin Transl Oncol. 2025 Jun;27(6):2544-2556. doi: 10.1007/s12094-024-03789-7. Epub 2024 Dec 5.
3
Repurposing of PSMA-targeted diagnostic and therapeutic agents for the detection and treatment of giant cell tumors of bone.
将靶向前列腺特异性膜抗原(PSMA)的诊断和治疗药物重新用于骨巨细胞瘤的检测和治疗。
Front Oncol. 2024 Nov 15;14:1504514. doi: 10.3389/fonc.2024.1504514. eCollection 2024.
4
Prostate-Specific Membrane Antigen Biology and Pathophysiology in Prostate Carcinoma, an Update: Potential Implications for Targeted Imaging and Therapy.前列腺特异性膜抗原在前列腺癌中的生物学和病理生理学:更新:对靶向成像和治疗的潜在影响。
Int J Mol Sci. 2024 Sep 9;25(17):9755. doi: 10.3390/ijms25179755.
5
Cyclohexanediamine Triazole (CHDT) Functionalization Enables Labeling of Target Molecules with AlF/Ga/In.环已二胺三唑(CHDT)功能化使目标分子能够用 AlF/Ga/In 进行标记。
Bioconjug Chem. 2024 Sep 18;35(9):1402-1416. doi: 10.1021/acs.bioconjchem.4c00313. Epub 2024 Aug 26.
6
Enhanced Prostate-specific Membrane Antigen Targeting by Precision Control of DNA Scaffolded Nanoparticle Ligand Presentation.通过精确控制 DNA 支架纳米颗粒配体呈递来增强前列腺特异性膜抗原靶向性。
ACS Nano. 2024 Jul 2;18(26):16674-16683. doi: 10.1021/acsnano.4c01640. Epub 2024 Jun 22.
7
PSMA-targeted radiotheranostics in modern nuclear medicine: then, now, and what of the future?PSMA 靶向放射性核素治疗在现代核医学中的应用:过去、现在和未来?
Theranostics. 2024 May 13;14(8):3043-3079. doi: 10.7150/thno.92612. eCollection 2024.
8
Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer.前列腺特异性膜抗原PET反应与寡转移前列腺癌立体定向消融放疗后的无转移生存期相关。
Adv Radiat Oncol. 2024 Apr 13;9(7):101507. doi: 10.1016/j.adro.2024.101507. eCollection 2024 Jul.
9
Synthesis and Preclinical Evaluation of Two Novel Ga-Labeled Bispecific PSMA/FAP-Targeted Tracers with 2-Nal-Containing PSMA-Targeted Pharmacophore and Pyridine-Based FAP-Targeted Pharmacophore.两种新型 Ga 标记双特异性 PSMA/FAP 靶向示踪剂的合成及临床前评价:含有 2-Nal-PSMA 靶向药效团和吡啶基 FAP 靶向药效团。
Molecules. 2024 Feb 9;29(4):800. doi: 10.3390/molecules29040800.
10
Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises.研发叶酸偶联 miR-34a 治疗前列腺癌:挑战与前景。
Int J Mol Sci. 2024 Feb 9;25(4):2123. doi: 10.3390/ijms25042123.